Hyperandrogenemia Predicts Metabolic Phenotype in Polycystic Ovary Syndrome: The Utility of Serum Androstenedione-Reference-Cited by-同舟云学术

Hyperandrogenemia Predicts Metabolic Phenotype in Polycystic Ovary Syndrome: The Utility of Serum Androstenedione

Published:2014-03-01 Issue:3 Volume:99 Page:1027-1036
ISSN:0021-972X
Container-title:The Journal of Clinical Endocrinology & Metabolism
language:en
Short-container-title:

Author:

O'Reilly Michael W.¹,Taylor Angela E.¹,Crabtree Nicola J.²,Hughes Beverly A.¹,Capper Farfia³,Crowley Rachel K.¹,Stewart Paul M.¹⁴,Tomlinson Jeremy W.¹,Arlt Wiebke¹

Affiliation:

1. Centre for Endocrinology, Diabetes, and Metabolism (M.W.O., A.E.T., B.A.H., R.K.C., P.M.S., J.W.T., W.A.), School of Clinical and Experimental Medicine, University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom

2. Department of Nuclear Medicine (N.J.C.), University Hospitals Birmingham, Edgbaston, United Kingdom

3. National Institute of Health Research/Wellcome Trust Clinical Research Facility (F.C.), University Hospitals Birmingham National Health Service Foundation Trust, Birmingham B15 2TH, United Kingdom

4. University of Leeds (P.M.S.), Leeds, LS2 9NL, United Kingdom

Publisher

The Endocrine Society

Subject

Biochemistry, medical,Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Link

http://academic.oup.com/jcem/article-pdf/99/3/1027/11158044/jcem1027.pdf

Reference47 articles.

1. Polycystic ovary syndrome;Franks;N Engl J Med,1995

2. The prevalence and features of the polycystic ovary syndrome in an unselected population;Azziz;J Clin Endocrinol Metab,2004

3. Consensus on women's health aspects of polycystic ovary syndrome (PCOS): The Amsterdam ESHRE/ASRM-sponsored 3rd PCOS Consensus Workshop Group;Fauser;Fertil Steril,2012

4. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS);Hum Reprod,2004